A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy Source: RI-MUHC
Join us for the finalist pitches at the 4th annual...
Please join us for a special Bicentennial panel event on...
Canadian Task Force on Preventive Health Care recommends routine screening...
By David McFadden...
Technology offers more accurate method to detect illness in minimally symptomatic cases...
Finding could lead to potential therapies
RSS